HB0845 authorizes the Maryland Department of Health, in consultation with local health departments, to approve up to six community-based Overdose and Infectious Disease Prevention Services Programs statewide. These programs may be operated by qualifying community-based organizations, including hospitals, clinics, treatment centers, federally qualified health centers, local health departments, faith-based organizations, and similar entities. The bill sets out a detailed framework for what each program must provide, including supervised consumption of preobtained drugs, sterile supplies, overdose monitoring and reversal with naloxone, first aid, referrals to substance use treatment and other health services, education on safer use and disease prevention, and staff training and security requirements.
The bill also allows programs to bill insurance carriers for covered services with the participant’s consent, accept donations and grants, apply for public or private grants, coordinate with other outreach and syringe services programs, and use mobile facilities. Programs may not be located in areas zoned for residential uses. The Department must approve or deny applications within 45 days and provide a written explanation. The bill includes annual reporting requirements to the Department and legislative committees on participation, services provided, overdoses reversed, referrals, and other impact data. It is set to take effect July 1, 2025, and sunset on June 30, 2029.
The bill’s impact would be to add a new subtitle to the Health-General Article creating a limited, state-authorized framework for overdose prevention sites and related infectious disease prevention services. It would provide legal protections from arrest, prosecution, civil or administrative penalties, licensing discipline, and property seizure for participants, staff, volunteers, and property owners acting within the program’s scope, while preserving criminal liability for unauthorized activities. It would also create a new regulatory role for the Maryland Department of Health and local health departments in approving, overseeing, and evaluating these programs.
Overall sentiment appears supportive and public-health oriented, as reflected by the large number of sponsors and the bill’s focus on overdose prevention, naloxone access, treatment referrals, and disease reduction. The available voting history shows strong legislative support in the Senate, where the bill passed third reading 40-0 with amendments. No committee transcript or recorded opposition is provided in the materials, so the main points of contention are not documented here.
Potential areas of contention inherent in the bill include the authorization of supervised consumption services, the limited number of sites, the requirement that programs not be located in residentially zoned areas, and the scope of legal immunity provided to participants and operators. The bill also raises operational questions about insurance billing, security, site approval, and how the Department will select among urban, suburban, and rural locations.
HB0845 would create a new statutory program in the Maryland Health-General Article authorizing a tightly regulated network of overdose and infectious disease prevention services sites. It would expand state law by defining eligible operators, setting approval criteria, granting legal protections for lawful program activity, and requiring annual reporting to state and legislative oversight bodies. The bill would affect community-based organizations, health providers, local health departments, insurers, property owners, and individuals who use the services, while also establishing a temporary pilot structure that sunsets after four years.
The most likely points of contention are the authorization of supervised drug consumption services, the extent of immunity from arrest, prosecution, penalties, and property seizure, and the decision to limit the number and location of programs. Critics may object to the bill on moral, public safety, zoning, or neighborhood-impact grounds, while supporters are likely to emphasize overdose reversal, disease prevention, and linkage to treatment. The bill’s restrictions on residential zoning and its cap of six programs indicate an effort to address some of those concerns.